A groundbreaking study from Korea has challenged conventional wisdom in treating severe hypernatremia, a condition characterized by elevated sodium levels in the blood. The research, led by Sejoong Kim and colleagues, compared two fluid replacement strategies: rapid intermittent bolus (RIB) and slow continuous infusion (SCI). The findings, to be presented at the 2025 American Society of Nephrology Kidney Week meeting, suggest that both methods are equally effective and safe, but with some intriguing differences.
The study enrolled 178 patients with dangerously high serum sodium levels (155 mmol/L or higher) and randomly assigned them to receive either intermittent boluses or continuous infusions of electrolyte-free water. The primary goal was to rapidly correct sodium levels, defined as a reduction of at least 6 mmol/L within 24 hours or reaching a level of 150 mmol/L or lower.
The results were eye-opening. Rapid correction was achieved in an impressive 91.0% of patients treated with RIB and 88.8% with SCI, with no significant difference between the two methods (P=0.62). However, the RIB group experienced a faster initial drop in sodium levels within the first 6 hours (-4.7 ± 2.6 vs -3.6 ± 2.6 mmol/L; P=0.004) and required less total fluid over 48 hours (1,976 ± 1,285 vs 2,506 ± 1,705 mL; P=0.04).
Despite these differences, the target correction rates, overcorrection rates, and 28-day survival rates were remarkably similar between the two groups. The investigators concluded that both methods effectively lowered serum sodium without significant safety concerns.
But here's where it gets controversial: the RIB approach not only achieved faster initial sodium reduction but did so with lower fluid volumes, suggesting it may help prevent fluid overload, a common concern in hypernatremia treatment. This finding challenges the traditional belief that slower, continuous infusion is always safer.
The study's implications are significant. It supports the feasibility of a simplified correction protocol that doesn't rely on complex electrolyte-free water clearance calculations, potentially making treatment more accessible and efficient.
So, what do you think? Is the RIB approach the way forward for severe hypernatremia treatment? Or does the traditional SCI method still have its advantages? Share your thoughts in the comments and let's spark a discussion on this intriguing topic!
